The United States is currently in the midst of a
public health crisis due to the opioid epidemic which is impacting the
population at all points across the developmental life span. Medication
treatment for opioid use disorders decreases risk for overdose and death yet
these medications are less commonly prescribed to youth relative to older
adults. This presentation will review morbidity associated with opioid misuse
in youth including common co-occurring medical and psychiatric conditions that
are important to assess. Strategies to increase youth engagement with
medication for opioid use disorders will be reviewed including the role of
family involvement and interprofessional team members in addition to the
clinician prescribing medication for the opioid use disorder.
As a result of
participating in this webinar, you will be able to:
- Discuss medical and psychiatric co-morbidity associated with opioid use
disorders in transitional age youth;
- Identify why it is important to discuss medication for opioid use
disorders with transitional age youth;
- Describe strategies to increase youth engagement with medication for
opioid use disorders;
- Describe the roles of interprofessional team members when providing
medication treatment to transitional aged youth; and
- Describe evidence-based individual and family education and behavioral
health interventions for transitional-aged youth and their families.
